Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 28, 2017 17:20 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. Announces Proposed Public Offering of Common Stock

RANCHO CORDOVA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based...
November 28, 2017 07:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent

RANCHO CORDOVA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing today announced that on November 21, 2017, the U.S....
November 22, 2017 07:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Appoints Healthcare Investment Banking Veteran Joe E. Balagot as Senior Vice President of Corporate Development

RANCHO CORDOVA, Calif., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
November 14, 2017 16:05 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update

RANCHO CORDOVA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
November 14, 2017 07:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017

RANCHO CORDOVA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
November 07, 2017 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Announce Financial Results for the Three Months Ended September 30, 2017 and Host Conference Call on November 14th

RANCHO CORDOVA, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
October 03, 2017 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Receives Notice of Allowance for U.S. Patent Application Covering a Novel Method of Cell Separation

RANCHO CORDOVA, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
September 27, 2017 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Present at the 2017 Cell & Gene Meeting on the Mesa

RANCHO CORDOVA, Calif., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
September 25, 2017 13:23 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017

RANCHO CORDOVA, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
September 19, 2017 16:05 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update

RANCHO CORDOVA, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...